Table 3.
Associated drug (%) and entrapment drug quantity (µg/mg) of amphiphilic CD nanoparticles for PCX (CD amount is 0.5 mg/mL and initial PCX amount is 0.05 mg/mL in all formulations) (n = 3, ± SD).
| Nanoparticle formulations | Percentage associated drug ± SD | Entrapment drug quantity ± SD (µg/mg) |
| 6OCaproβCD | 41 ± 2 | 4.4 ± 0.4 |
| CS-6OCaproβCD | 62 ± 5 | 5.6 ± 1.3 |
| PC βCDC6 | 64 ± 2 | 6.3 ± 0.7 |